Actively Recruiting
A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
Led by Keymed Biosciences Co.Ltd · Updated on 2025-12-17
158
Participants Needed
3
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the efficacy and safety of CM336 (BCMA/CD3 Bispecific Antibody) in the treatment of patients with relapsed or refractory autoimmune cytopenia
CONDITIONS
Official Title
A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntary provision of written informed consent and ability to comply with protocol requirements.
- Age 18 years or older, male or female.
- Eastern Cooperative Oncology Group Performance Status of 0 to 2.
- Confirmed diagnosis of immune thrombocytopenia, warm autoimmune hemolytic anemia, cold agglutinin disease, mixed autoimmune hemolytic anemia, or Evans Syndrome.
- Relapsed or refractory autoimmune hemolytic anemia.
You will not qualify if you...
- Secondary immune thrombocytopenia or autoimmune hemolytic anemia caused by any reason.
- Other types of autoimmune hemolytic anemia or other types of cytopenia.
- History of critical diseases that pose a safety risk or could affect study results.
- Previous treatment with anti-B Cell Maturation Antigen antibody.
- Investigator's judgment of unsuitability for participation.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Henan Cancer Hospital
Zhengzhou, Henan, China
Actively Recruiting
2
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, China
Actively Recruiting
3
Blood Disease Hospital, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China
Actively Recruiting
Research Team
Q
Qian Jia
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here